720 related articles for article (PubMed ID: 11520320)
1. The management of refractory idiopathic epilepsies.
Perucca E
Epilepsia; 2001; 42 Suppl 3():31-5. PubMed ID: 11520320
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
[TBL] [Abstract][Full Text] [Related]
3. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
[TBL] [Abstract][Full Text] [Related]
4. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Hosford DA; Wang Y
Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
[TBL] [Abstract][Full Text] [Related]
5. Chronic management of seizures in the syndromes of idiopathic generalized epilepsy.
Bourgeois BF
Epilepsia; 2003; 44 Suppl 2():27-32. PubMed ID: 12752459
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital.
Habib M; Khan SU; Hoque A; Mondal BA; Hasan AT; Chowdhury RN; Haque B; Rahman KM; Chowdhury AH; Ghose SK; Mohammad QD
BMC Res Notes; 2013 Nov; 6():473. PubMed ID: 24245810
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
[TBL] [Abstract][Full Text] [Related]
9. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):39-44. PubMed ID: 20559266
[TBL] [Abstract][Full Text] [Related]
10. Practical management issues for idiopathic generalized epilepsies.
Benbadis SR
Epilepsia; 2005; 46 Suppl 9():125-32. PubMed ID: 16302886
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and adverse effects of established and new antiepileptic drugs.
Mattson RH
Epilepsia; 1995; 36 Suppl 2():S13-26. PubMed ID: 8784211
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
[TBL] [Abstract][Full Text] [Related]
13. Primary Generalized Epilepsies.
Murphy K; Delanty N
Curr Treat Options Neurol; 2000 Nov; 2(6):527-542. PubMed ID: 11096777
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
15. Standard approach to antiepileptic drug treatment in the United States.
Pellock JM
Epilepsia; 1994; 35 Suppl 4():S11-8. PubMed ID: 8174515
[TBL] [Abstract][Full Text] [Related]
16. Topiramate in refractory epilepsy: a prospective observational study.
Stephen LJ; Sills GJ; Brodie MJ
Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pediatric epilepsy: expert opinion, 2005.
Wheless JW; Clarke DF; Carpenter D
J Child Neurol; 2005 Dec; 20 Suppl 1():S1-56; quiz S59-60. PubMed ID: 16615562
[TBL] [Abstract][Full Text] [Related]
18. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].
Boldyreva SR; Ermakov AIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):39-44. PubMed ID: 21322824
[TBL] [Abstract][Full Text] [Related]
19. Management strategies for refractory localization-related seizures.
Brodie MJ
Epilepsia; 2001; 42 Suppl 3():27-30. PubMed ID: 11520319
[TBL] [Abstract][Full Text] [Related]
20. Role of valproate across the ages. Treatment of epilepsy in children.
Aldenkamp A; Vigevano F; Arzimanoglou A; Covanis A
Acta Neurol Scand Suppl; 2006; 184():1-13. PubMed ID: 16776492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
